1 England Patient Safety Alert NHS. Risk of severe harm or death when desmopressin is omitted or delayed in patients with cranial diabetes insipidus. 2016. https://www.england. nhs.uk/2016/02/psa-desmopressin/
2 Bockenhauer D, Bichet DG. Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus. Nat Rev Nephrol 2015;11:576-88. 10.1038/nrneph.2015.89 26077742
3 Garrahy A, Moran C, Thompson CJ. Diagnosis and management of central diabetes insipidus in adults. Clin Endocrinol (Oxf) 2019;90:23-30. 10.1111/cen.13866 30269342
4 Psychogenic polydipsia. BMJ Best Practice 2018. https://bestpractice.bmj.com/topics/engb/865
5 de Leon J, Verghese C, Tracy JI, Josiassen RC, Simpson GM. Polydipsia and wáter intoxication in psychiatric patients: a review of the epidemiological literature. Biol Psychiatry 1994;35:408-19. 10.1016/0006-3223(94)90008-6 8018788
6 Milles JJ, Spruce B, Baylis PH. A comparison of diagnostic methods to differentiate diabetes insipidus from primary polyuria: a review of 21 patients. Acta Endocrinol (Copenh) 1983;104:410-6. 10.1530/acta.0.1040410 6659843
7 Fujimoto M, Okada S, Kawashima Y, etal . Clinical overview of nephrogenic diabetes insipidus based on a nationwide survey in Japan. Yonago Acta Med 2014;57:85-91.25324589
8 Fenske W, Refardt J, Chifu I, etal . A copeptin-based approach in the diagnosis of diabetes insipidus. N Engl J Med 2018;379:428-39. 10.1056/NEJMoa1803760 30067922
Comentarios
Usted debe ingresar al sitio con su cuenta de usuario IntraMed para ver los comentarios de sus colegas o para expresar su opinión. Si ya tiene una cuenta IntraMed o desea registrase, ingrese aquí